| Didier
Hans, Ph.D., MBA, is currently Head of the Research and Development
in the Radiology Department, Nuclear Medicine Division at the University
of Geneva, Switzerland. He is also a cofounder of Synarc, Inc. He has 15
years of Clinical Research experience and is recognized as an expert on
the cutting edge of Dual Energy XrayAbsorptiometry (DXA)and Quantitative
Ultrasound Systems (QUS) technologies. He has particular expertise in validating
and optimizing new technologies as well as developing DXA and ultrasound
protocol, quality assurance and training of research assistants for large,
multicenter clinical trials.
Dr. Hans has a Ph.D. in human biology and medical physics, with honors, from Claude Bernard University in Lyon, France and was a recipient of the Young Investigators Award from the American Society of Bone and Mineral Research Annual Meeting in 1995. He also has a Masters of Science degree, with honors, in Medical Physics from Claude Bernard University.More recently, Dr Didier Hans accomplished an executive MBA with honors from the "Hautes Etudes Commercials (HEC) at Geneva University in Switzerland. He is an active member of eight international societies and advisory boards. He continues to teach courses in DXA, Ultrasound and Osteoporosis and lectures around the world. Also, he serves as a reviewer for seven international scientific journals, has published more than 80 articles and has contributed chapters to over 20 books. Dr. Hans was the Associate Director of the Quality Assurance Center for Clinical Research and the Director of Research and Development for the ultrasound unit at the Osteoporosis and Arthritis Research Group (OARG) of the University of California San Francisco, San Francisco CA. Also, he has held similar positions in Europe at the Centre d'Epidémiologie des Ostéoporoses in Lyon, France. While at d'Epidémiologie des Ostéoporoses, he was Director of the Bone Densitometry and new technologies department, as well as Director of the Quality Control Department. |